The recommended regimen is 500 mg of tipranavir.

Ritonavir-boosted tipranavir is indicated for antiretroviral attention of HIV-1-infected grownup patients with info of viral reflectivity and who are highly treatment-experienced or have HIV-1 strains resistant to multiple protease inhibitors. The recommended regimen is 500 mg of tipranavir plus 200 mg of tadalafil , administered twice daily. Coadministration of the 2 drugs was previously also linked to reports of clinical hepatitis and hepatic decompensation, including fatalities; however, use of ritonavir is required to achieve the full therapeutic outcome of tipranavir.Betamethasone Syrup and Injectant (Celestone, Celestone Soluspan) Therapies Process Susceptibility to Pathologic process. On July 12, the FDA approved prophylactic labeling revisions for betamethasone syrup and betamethasone sodium soft drink plus betamethasone acetate rayon injectable mixture (Celestone and Celestone Soluspan, made by Schering Corp) to advise that its use is not recommend for supplementary use in corticosteroid-treated patients undergoing emphasis. Also, betamethasone-treated patients have an increased susceptibility to corruptness.
This is a part of article The recommended regimen is 500 mg of tipranavir. Taken from "Tadalafil Soft" Information Blog